3-9867171-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001321142.2(CIDEC):c.680C>T(p.Ser227Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 1,613,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001321142.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIDEC | NM_001321142.2 | c.680C>T | p.Ser227Leu | missense_variant | 7/7 | ENST00000336832.7 | NP_001308071.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIDEC | ENST00000336832.7 | c.680C>T | p.Ser227Leu | missense_variant | 7/7 | 1 | NM_001321142.2 | ENSP00000338642 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152276Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000131 AC: 33AN: 251478Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135918
GnomAD4 exome AF: 0.000223 AC: 326AN: 1461532Hom.: 0 Cov.: 32 AF XY: 0.000219 AC XY: 159AN XY: 727062
GnomAD4 genome AF: 0.000105 AC: 16AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.680C>T (p.S227L) alteration is located in exon 6 (coding exon 5) of the CIDEC gene. This alteration results from a C to T substitution at nucleotide position 680, causing the serine (S) at amino acid position 227 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at